Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $13.8050 (-0.97%) ($13.8050 - $13.8050) on Tue. Aug. 30, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.31% (three month average) | RSI | 38 | Latest Price | $13.8050(-0.97%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.9% a day on average for past five trading days. | Weekly Trend | BCRX declines -1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLK(33%) VT(32%) VUG(32%) BLOK(30%) URA(30%) | Factors Impacting BCRX price | BCRX will decline at least -2.155% in a week (0% probabilities). VIXM(-16%) UUP(-14%) SMH(-10%) EDOC(-6%) VXX(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.155% (StdDev 4.31%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $14.18 | 5 Day Moving Average | $14.33(-3.66%) | 10 Day Moving Average | $14.27(-3.26%) | 20 Day Moving Average | $14.18(-2.64%) | To recent high | -6.8% | To recent low | 52% | Market Cap | $2.436b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |